Tasosartan
Tasosartan Basic information
- Product Name:
- Tasosartan
- Synonyms:
-
- TASOSARTAN
- 2,4-Dimethyl-8-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5,6-dihydropyrido[6,5-d]pyrimidin-7-one
- AC1L1U5X
- AC1Q6LAA
- ANA-756
- DB01349
- S1539_Selleck
- 5,8-Dihydro-2,4-dimethyl-8-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]pyrido[2,3-d]pyrimidin-7(6H)-one
- CAS:
- 145733-36-4
- MF:
- C23H21N7O
- MW:
- 411.46
- Mol File:
- 145733-36-4.mol
Tasosartan Chemical Properties
- Melting point:
- 197-199°
- Boiling point:
- 759.4±70.0 °C(Predicted)
- Density
- 1.328±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- DMSO (Slightly), Methanol (Slightly, Sonicated)
- form
- Solid
- pka
- 4.16±0.10(Predicted)
- color
- White to Off-White
Tasosartan Usage And Synthesis
Uses
Antihypertensive.
Uses
Tasosartan is an angiotensin II receptor antagonist.
Definition
ChEBI: Tasosartan is a member of biphenyls.
Synthesis
149049-80-9
145733-36-4
Step 6) A mixture of 2,4-dimethyl-5,6,8-trihydro-8-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-7H-pyrido[2,3-d]pyrimidin-7-one and 2,4-dimethyl-5,6,8-trihydro-8-[[2'-(1-tert-butyl-1H-tetrazol-5-yl)[1,1'-biphenyl]-4 -yl]methyl]-7H-pyrido[2,3-d]pyrimidin-7-one mixture (200 mg, 0.428 mmol) was dissolved in toluene (4 mL), methanesulfonic acid (280 mL, 4.28 mmol) was added, and heated to reflux for 18 hours. Upon completion of the reaction, the mixture was concentrated and adjusted to pH 8 by the addition of water (2 mL) and 1N KOH solution (4.5 mL).The mixture was extracted with ethyl acetate (EtOAc) to remove unreacted feedstock, followed by acidification of the aqueous phase to pH 5 with 1N HCl to give a gelatinous precipitate. The precipitate was dissolved in ethyl acetate and the solution was dried over anhydrous magnesium sulfate (MgSO4) and concentrated to give a colorless oil. Grinding with a solvent mixture of acetone/ether gave 70 mg (40% yield) of the target product as a white solid with a melting point of 197°C-198°C.1H NMR (DMSO-d6) δ: 2.35 (s, 3H), 2.42 (s, 3H), 2.72 (t, J = 7.2 Hz, 2H), 2.87 (t, J = 7.2 Hz, 2H), 2.17 (s, 2H), 2.17 (s, 2H). 5.17 (s, 2H), 6.99 (d, J = 8.2 Hz, 2H), 7.18 (d, J = 8.2 Hz, 2H), 7.54 (m, 2H), 7.65 (m, 2H). ir (KBr, cm-1): 1710 (C=O).
in vivo
Administration of Tasosartan at doses of 1.0 and 3.0 mg/kg (iv) significantly (p<0.05) attenuates the pressor response to angiotensin-II in rats[2].
IC 50
AT1 Receptor
References
[1] Patent: US5256654, 1993, A
[2] Patent: US5149699, 1992, A
TasosartanSupplier
- Tel
- sales@boylechem.com
- Tel
- 13817811078
- sales@jingyan-chemical.com
- Tel
- 1-(800)-881-8210
- inquiries@lgmpharma.com
- Tel
- 0571-82693216
- info@yuhaochemical.com
- Tel
- 021-56491756 13512199871
- 2819742715@qq.com
Tasosartan(145733-36-4)Related Product Information
- Dimethyl sulfoxide
- N,N-Dimethylformamide
- Tazobactam sodium
- N,N-Dimethylaniline
- Dimethicone
- Dimethyl disulfide
- Dimethyl sulfate
- Dimethyl fumarate
- Tazobactam acid
- ETHANE
- Dacthal
- Dimethyl ether
- Dimethyl carbonate
- Dimethyl phthalate
- Poly(dimethylsiloxane)
- N,N-Dimethylacetamide
- Diethyl 1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
- 5-(2-METHYLPHENYL)-1H-TETRAZOLE